Business
For example, we retain a short period of our business interruption losses.
Delek US Holdings, Inc.: Revenue declined 9.5% to $10.72B from $11.85B. Net loss narrowed to $22.8M from $560M. Free cash flow turned positive at $6.3M from a $495M outflow. Operating margin expanded 696 bps to 2.81%. Delek US Holdings, Inc.'s annual comparison also shows stock compensation grew faster than revenue; capital spending grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 9.5% to $10.72B from $11.85BWatch
- Profitability — Net loss narrowed to $22.8M from $560MOK
- Cash flow — Free cash flow turned positive at $6.3M from a $495M outflowOK
- Margins — Operating margin expanded 696 bps to 2.81%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 27 salesWatch
Where the revenue comes from
Fiscal 2025, as Delek US Holdings, Inc. reports it. History and quarterly detail are in the app.
- Refining$10.2B
- Logistics$513.8M
Leadership changes
From Delek US Holdings, Inc.'s own filings, the day they're filed.
- Misty Lavender · President · appointmenteff. 2026-07-01
- Mark Hobbs · Chief Financial Officer · appointmenteff. 2026-07-01
- Joseph Israel · President · departureeff. 2026-04-20
Latest filings
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-07-23
- 8-K · Company announcement2026-07-02
- 8-K · Company announcement2026-05-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Delek US Holdings, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.